Discontinuing lipid-lowering agents

被引：2
|
作者：
Davis, George F.
机构：
来源：
JOURNAL OF PALLIATIVE MEDICINE | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1089/jpm.2006.9.619
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：619 / 619
页数：1
相关论文
共 50 条
  • [21] Hepatotoxicity of statins and other lipid-lowering agents
    Bjornsson, Einar S.
    LIVER INTERNATIONAL, 2017, 37 (02) : 173 - 178
  • [22] Re: Lipid-lowering agents and risk of melanoma
    Friis, S
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 334 - 334
  • [23] Lipid levels and the use of lipid-lowering agents in England and Scotland
    Primatesta, P
    Poulter, NR
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2004, 11 (06): : 484 - 488
  • [24] Use of lipid-lowering agents (statins) during pregnancy
    Hosokawa, A
    Bar-Oz, B
    Ito, S
    CANADIAN FAMILY PHYSICIAN, 2003, 49 : 747 - 749
  • [25] Lipid-lowering agents for preventing melanoma: An ongoing review
    Dellavalle, RP
    Drake, A
    Graber, M
    McNealy, K
    Morelli, J
    Schilling, LM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1317S - 1317S
  • [26] CUTANEOUS SIDE-EFFECTS OF LIPID-LOWERING AGENTS
    PROKSCH, E
    HAUTARZT, 1995, 46 (02): : 76 - 80
  • [27] Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety
    Shatnawi, Aymen
    Kamran, Zourayz
    Al-Share, Qusai
    PERSONALIZED MEDICINE, 2023, 20 (01) : 65 - 85
  • [28] New lipid-lowering agents acting on LDL receptors
    Scharnagl, H
    März, W
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (03) : 233 - 242
  • [29] Lipid-lowering agents and new onset diabetes mellitus
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (12) : 1965 - 1970
  • [30] Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities
    Rosenson, RS
    ATHEROSCLEROSIS, 2004, 173 (01) : 1 - 12
12345